Xtant Medical Holdings (XTNT) Cash from Financing Activities (2010 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Cash from Financing Activities came in at -$5.8 million in Q3 2025, down 208.6% year-over-year from $5.3 million in Q3 2024, and down 971.75% quarter-over-quarter from $662000.0 in Q2 2025.
Powered by 
Analysis
Xtant Medical Holdings (XTNT) Cash from Financing Activities (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Cash from Financing Activities for 16 consecutive years, with -$5.8 million the latest figure, recorded in Q3 2025.
- On a quarterly basis, Cash from Financing Activities fell 208.6% year-over-year to -$5.8 million in Q3 2025; TTM through Sep 2025 was -$6.9 million, a 139.89% decrease from a year earlier, with the FY2024 full-year figure at $16.1 million, down 18.37% from the prior year.
- Cash from Financing Activities was -$5.8 million for Q3 2025 at Xtant Medical Holdings, down from $662000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $18.1 million in Q1 2021 and troughed at -$5.8 million in Q3 2025.
- A 5-year average of $3.0 million and a median of $662000.0 in 2025 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 53311.76% in 2021, down 1515.0% in 2021.
- Over 5 years, Cash from Financing Activities stood at -$55000.0 in 2021, then soared by 10307.27% to $5.6 million in 2022, then plunged by 94.21% to $325000.0 in 2023, then tumbled by 362.77% to -$854000.0 in 2024, then tumbled by 575.76% to -$5.8 million in 2025.
- The last three Cash from Financing Activities figures came in at -$5.8 million (Q3 2025), $662000.0 (Q2 2025), and -$919000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Xtant Medical Holdings | 47.61 Mn | 30.01 Mn | 17.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -5.77 Mn |
| Jun 30, 2025 | 662,000.00 |
| Mar 31, 2025 | -919,000.00 |
| Dec 31, 2024 | -854,000.00 |
| Sep 30, 2024 | 5.31 Mn |
| Jun 30, 2024 | 6.43 Mn |
| Mar 31, 2024 | 5.18 Mn |
| Dec 31, 2023 | 325,000.00 |
| Sep 30, 2023 | 12.84 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Mar 31, 2023 | 4.57 Mn |
| Dec 31, 2022 | 5.61 Mn |
| Sep 30, 2022 | 3.31 Mn |
| Jun 30, 2022 | 115,000.00 |
| Mar 31, 2022 | -21,000.00 |
| Dec 31, 2021 | -55,000.00 |
| Sep 30, 2021 | -646,000.00 |
| Jun 30, 2021 | 106,000.00 |
| Mar 31, 2021 | 18.09 Mn |
| Dec 31, 2020 | -746,000.00 |